Table 2.
The Main Pharameters after Oral Administration of Ost-suspension and Ost-S100-NPs in rats. Mean ± SE (n = 8).
Parameters |
Units |
Ost-suspension |
Ost-S100-NP |
Cmax | μg·ml−1 | 1.87 ± 0.24 | 3.15 ± 0.29** |
Tpeak | h | 2.25 ± 0.21 | 4.21 ± 0.25** |
ka | h−1 | 1.25 ± 0.16 | 0.44 ± 0.09** |
k10 | h−1 | 0.43 ± 0.02 | 0.45 ± 0.02* |
AUC | μg·h·ml−1 | 55.47 ± 3.33 | 93.58 ± 4.85** |
CL | mg·kg−1·h−1/ μg·ml−1 | 0.45 ± 0.02 | 0.27 ± 0.01** |
MRT | h | 22.10 ± 0.87 | 23.48 ± 0.64** |
Fr(%) | — | 168.7% |
Notes.
P < 0.05 vs. Ost-suspension;
P < 0.01 vs. Ost-suspension.
Cmax: maximum concentration; Tpeak: time to reach Cmax; ka: the absorption constant from gastrointestinal tract to central compartment; k10: elimination constant of the central compartment; AUC:area under concentration curve; CL: clearance; MRT: mean retention time; Relative bioavailability: Fr % = ( AUCOst-S100-NP / AUCOst-suspension) × 100%